Cargando…
Basal Cell Carcinoma: From the Molecular Understanding of the Pathogenesis to Targeted Therapy of Progressive Disease
Due to intensified research over the past decade, the Hedgehog (HH) pathway has been identified as a pivotal defect implicated in roughly 25% of all cancers. As one of the most frequent cancer worldwide, the development of Basal cell carcinoma (BCC) due to activation of the HH pathway has been convi...
Autores principales: | Göppner, Daniela, Leverkus, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021865/ https://www.ncbi.nlm.nih.gov/pubmed/21253551 http://dx.doi.org/10.1155/2011/650258 |
Ejemplares similares
-
Prognostic Parameters for the Primary Care of Melanoma Patients: What Is Really Risky in Melanoma?
por: Göppner, Daniela, et al.
Publicado: (2011) -
Understanding the Molecular Genetics of Basal Cell Carcinoma
por: Pellegrini, Cristina, et al.
Publicado: (2017) -
Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma
por: Hoashi, Toshihiko, et al.
Publicado: (2022) -
Current progress in understanding the molecular pathogenesis of burn scar contracture
por: Tan, Jianglin, et al.
Publicado: (2017) -
Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma
por: Kim, Jung Guk
Publicado: (2014)